Marathon Oil Corporation   Report issue

For profit Phase 1
Founded: Houston TX United States (1887)
Status: No NME R&D (1887)

Organization Overview

First Clinical Trial
2015
NCT02418962
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Marathon Oil Corporation

Active Ingredients

Drugs in Phase 1 Trials (2)

pfspz (2 trials)

pfspz vaccine (4 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Malaria (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 4
  • # of Trial APIs: 2